table of content
1 Introduction to Research & Analysis Reports
1.1 Cellular and Gene Therapy CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cellular and Gene Therapy CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cellular and Gene Therapy CDMO Overall Market Size
2.1 Global Cellular and Gene Therapy CDMO Market Size: 2022 VS 2032
2.2 Global Cellular and Gene Therapy CDMO Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cellular and Gene Therapy CDMO Players in Global Market
3.2 Top Global Cellular and Gene Therapy CDMO Companies Ranked by Revenue
3.3 Global Cellular and Gene Therapy CDMO Revenue by Companies
3.4 Top 3 and Top 5 Cellular and Gene Therapy CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cellular and Gene Therapy CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cellular and Gene Therapy CDMO Players in Global Market
3.6.1 List of Global Tier 1 Cellular and Gene Therapy CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Cellular and Gene Therapy CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cellular and Gene Therapy CDMO Market Size Markets, 2022 & 2032
4.1.2 Cell Therapy
4.1.3 Viral Vectors
4.1.4 Plasmid
4.2 By Type - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
4.2.1 By Type - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
4.2.2 By Type - Global Cellular and Gene Therapy CDMO Revenue, 2023-2032
4.2.3 By Type - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cellular and Gene Therapy CDMO Market Size, 2022 & 2032
5.1.2 Commercial
5.1.3 Academic Research
5.1.4 Others
5.2 By Application - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
5.2.1 By Application - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
5.2.2 By Application - Global Cellular and Gene Therapy CDMO Revenue, 2023-2032
5.2.3 By Application - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cellular and Gene Therapy CDMO Market Size, 2022 & 2032
6.2 By Region - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
6.2.1 By Region - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
6.2.2 By Region - Global Cellular and Gene Therapy CDMO Revenue, 2023-2032
6.2.3 By Region - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.3.2 US Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.3.3 Canada Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.3.4 Mexico Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.4.2 Germany Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.3 France Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.4 U.K. Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.5 Italy Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.6 Russia Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.7 Nordic Countries Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.8 Benelux Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.5.2 China Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5.3 Japan Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5.4 South Korea Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5.5 Southeast Asia Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5.6 India Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.6.2 Brazil Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.6.3 Argentina Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.7.2 Turkey Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.7.3 Israel Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.7.4 Saudi Arabia Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.7.5 UAE Cellular and Gene Therapy CDMO Market Size, 2018-2032
7 Players Profiles
7.1 Catalent
7.1.1 Catalent Corporate Summary
7.1.2 Catalent Business Overview
7.1.3 Catalent Cellular and Gene Therapy CDMO Major Product Offerings
7.1.4 Catalent Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.1.5 Catalent Key News
7.2 Lonza
7.2.1 Lonza Corporate Summary
7.2.2 Lonza Business Overview
7.2.3 Lonza Cellular and Gene Therapy CDMO Major Product Offerings
7.2.4 Lonza Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.2.5 Lonza Key News
7.3 Charles River
7.3.1 Charles River Corporate Summary
7.3.2 Charles River Business Overview
7.3.3 Charles River Cellular and Gene Therapy CDMO Major Product Offerings
7.3.4 Charles River Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.3.5 Charles River Key News
7.4 The Discovery Labs
7.4.1 The Discovery Labs Corporate Summary
7.4.2 The Discovery Labs Business Overview
7.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Major Product Offerings
7.4.4 The Discovery Labs Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.4.5 The Discovery Labs Key News
7.5 BIOCENTRIQ
7.5.1 BIOCENTRIQ Corporate Summary
7.5.2 BIOCENTRIQ Business Overview
7.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Major Product Offerings
7.5.4 BIOCENTRIQ Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.5.5 BIOCENTRIQ Key News
7.6 FUJIFILM Diosynth Biotechnologies
7.6.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
7.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Major Product Offerings
7.6.4 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.6.5 FUJIFILM Diosynth Biotechnologies Key News
7.7 Exothera
7.7.1 Exothera Corporate Summary
7.7.2 Exothera Business Overview
7.7.3 Exothera Cellular and Gene Therapy CDMO Major Product Offerings
7.7.4 Exothera Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.7.5 Exothera Key News
7.8 WuXi AppTec
7.8.1 WuXi AppTec Corporate Summary
7.8.2 WuXi AppTec Business Overview
7.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Major Product Offerings
7.8.4 WuXi AppTec Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.8.5 WuXi AppTec Key News
7.9 Pharmaron
7.9.1 Pharmaron Corporate Summary
7.9.2 Pharmaron Business Overview
7.9.3 Pharmaron Cellular and Gene Therapy CDMO Major Product Offerings
7.9.4 Pharmaron Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.9.5 Pharmaron Key News
7.10 OBiO
7.10.1 OBiO Corporate Summary
7.10.2 OBiO Business Overview
7.10.3 OBiO Cellular and Gene Therapy CDMO Major Product Offerings
7.10.4 OBiO Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.10.5 OBiO Key News
7.11 Cell Therapies
7.11.1 Cell Therapies Corporate Summary
7.11.2 Cell Therapies Business Overview
7.11.3 Cell Therapies Cellular and Gene Therapy CDMO Major Product Offerings
7.11.4 Cell Therapies Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.11.5 Cell Therapies Key News
7.12 AGC Biologics
7.12.1 AGC Biologics Corporate Summary
7.12.2 AGC Biologics Business Overview
7.12.3 AGC Biologics Cellular and Gene Therapy CDMO Major Product Offerings
7.12.4 AGC Biologics Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.12.5 AGC Biologics Key News
7.13 Cytiva
7.13.1 Cytiva Corporate Summary
7.13.2 Cytiva Business Overview
7.13.3 Cytiva Cellular and Gene Therapy CDMO Major Product Offerings
7.13.4 Cytiva Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.13.5 Cytiva Key News
7.14 Helixmith
7.14.1 Helixmith Corporate Summary
7.14.2 Helixmith Business Overview
7.14.3 Helixmith Cellular and Gene Therapy CDMO Major Product Offerings
7.14.4 Helixmith Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.14.5 Helixmith Key News
7.15 ThermoGenesis
7.15.1 ThermoGenesis Corporate Summary
7.15.2 ThermoGenesis Business Overview
7.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Major Product Offerings
7.15.4 ThermoGenesis Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.15.5 ThermoGenesis Key News
7.16 Anemocyte
7.16.1 Anemocyte Corporate Summary
7.16.2 Anemocyte Business Overview
7.16.3 Anemocyte Cellular and Gene Therapy CDMO Major Product Offerings
7.16.4 Anemocyte Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.16.5 Anemocyte Key News
7.17 Thermo Fisher Scientific
7.17.1 Thermo Fisher Scientific Corporate Summary
7.17.2 Thermo Fisher Scientific Business Overview
7.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Major Product Offerings
7.17.4 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.17.5 Thermo Fisher Scientific Key News
7.18 CBM
7.18.1 CBM Corporate Summary
7.18.2 CBM Business Overview
7.18.3 CBM Cellular and Gene Therapy CDMO Major Product Offerings
7.18.4 CBM Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.18.5 CBM Key News
7.19 Bio Elpida
7.19.1 Bio Elpida Corporate Summary
7.19.2 Bio Elpida Business Overview
7.19.3 Bio Elpida Cellular and Gene Therapy CDMO Major Product Offerings
7.19.4 Bio Elpida Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.19.5 Bio Elpida Key News
7.20 Genezen
7.20.1 Genezen Corporate Summary
7.20.2 Genezen Business Overview
7.20.3 Genezen Cellular and Gene Therapy CDMO Major Product Offerings
7.20.4 Genezen Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.20.5 Genezen Key News
7.21 CCRM
7.21.1 CCRM Corporate Summary
7.21.2 CCRM Business Overview
7.21.3 CCRM Cellular and Gene Therapy CDMO Major Product Offerings
7.21.4 CCRM Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.21.5 CCRM Key News
7.22 RoslinCT
7.22.1 RoslinCT Corporate Summary
7.22.2 RoslinCT Business Overview
7.22.3 RoslinCT Cellular and Gene Therapy CDMO Major Product Offerings
7.22.4 RoslinCT Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.22.5 RoslinCT Key News
7.23 GenScript ProBio
7.23.1 GenScript ProBio Corporate Summary
7.23.2 GenScript ProBio Business Overview
7.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Major Product Offerings
7.23.4 GenScript ProBio Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.23.5 GenScript ProBio Key News
7.24 Oxford BioMedica
7.24.1 Oxford BioMedica Corporate Summary
7.24.2 Oxford BioMedica Business Overview
7.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Major Product Offerings
7.24.4 Oxford BioMedica Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.24.5 Oxford BioMedica Key News
7.25 Porton Pharma Solutions
7.25.1 Porton Pharma Solutions Corporate Summary
7.25.2 Porton Pharma Solutions Business Overview
7.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Major Product Offerings
7.25.4 Porton Pharma Solutions Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.25.5 Porton Pharma Solutions Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
